Literature DB >> 27641619

Isolation and Characterization of Fast-Migrating Human Glioma Cells in the Progression of Malignant Gliomas.

Vivian Adamski, Anne Dorothée Schmitt, Charlotte Flüh, Michael Synowitz, Kirsten Hattermann, Janka Held-Feindt.   

Abstract

Gliomas are the most common primary brain tumors. The most malignant form, the glioblastoma multiforme (GBM; WHO IV), is characterized by an invasive phenotype, which enables the tumor cells to infiltrate into adjacent brain tissue. When investigating GBM migration and invasion properties in vitro, in most cases GBM cell lines were analyzed. Comprehensive investigations focusing on progression-dependent characteristics of migration processes using fresh human glioma samples of different malignancy grades do not exist. Thus, we isolated fast-migrating tumor cells from fresh human glioma samples of different malignancy grades (astrocytomas WHO grade II, grade III, GBM, and GBM recurrences) and characterized them with regard to the transcription of genes involved in the migration and invasion, tumor progression, epithelial-to-mesenchymal transition, and stemness. In addition, we transferred our results to GBM cell lines and glioma stem-like cells and examined the influence of temozolomide on the expression of the above-mentioned genes in relation to migratory potential. Our results indicate that "evolutionary-like" expression alterations occur during glioma progression when comparing slow- and fast-migrating cells of fresh human gliomas. Furthermore, a close relation between migratory and stemness properties seems to be most likely. Variations in gene expression were also identified in GBM cell lines, not only when comparing fast- and slow-migrating cells but also regarding temozolomide-treated and untreated cells. Moreover, these differences coincided with the expression of stem cell markers and their migratory potential. Expression of migration-related genes in fast-migrating glioma cells is not only regulated in a progression-dependent manner, but these cells are also characterized by specific stem cell-like features.

Entities:  

Mesh:

Year:  2016        PMID: 27641619     DOI: 10.3727/096504016X14737243054982

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  5 in total

1.  Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma.

Authors:  Aierpati Maimaiti; Xixian Wang; Yujun Hao; Lei Jiang; Xin Shi; Yinan Pei; Zhaohai Feng; Maimaitijiang Kasimu
Journal:  J Mol Neurosci       Date:  2021-03-13       Impact factor: 3.444

2.  The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16.

Authors:  Vivian Adamski; Rolf Mentlein; Ralph Lucius; Michael Synowitz; Janka Held-Feindt; Kirsten Hattermann
Journal:  Int J Mol Sci       Date:  2017-07-08       Impact factor: 5.923

3.  Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.

Authors:  Richard E Kast; Nicolas Skuli; Georg Karpel-Massler; Guido Frosina; Timothy Ryken; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2017-06-01

4.  Modeling treatment-dependent glioma growth including a dormant tumor cell subpopulation.

Authors:  Marvin A Böttcher; Janka Held-Feindt; Michael Synowitz; Ralph Lucius; Arne Traulsen; Kirsten Hattermann
Journal:  BMC Cancer       Date:  2018-04-03       Impact factor: 4.430

Review 5.  Cancer stem cells in progression of colorectal cancer.

Authors:  Yujuan Zhou; Longzheng Xia; Heran Wang; Linda Oyang; Min Su; Qiang Liu; Jingguan Lin; Shiming Tan; Yutong Tian; Qianjin Liao; Deliang Cao
Journal:  Oncotarget       Date:  2017-12-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.